Dr. Michael Hoffman
University Health Network/University of Toronto Senior Scientist, Princess Margaret Cancer Centre/Associate Professor, Departments of Medical Biophysics and Computer Sc
Toronto, ON
Dr.
Michael Hoffman is a principal investigator at
Princess Margaret Cancer Centre and Associate Professor in the Departments of
Medical Biophysics and
Computer Science,
University of Toronto. He was named a
CIHR New Investigator and has received several awards for his academic work, including the
NIH K99/R00 Pathway to Independence Award, and the
Ontario Early Researcher Award. Dr. Hoffman creates predictive computational models to understand interactions between genome, epigenome, and phenotype in human cancers. He implemented the genome annotation method
Segway, which simplifies interpretation of large multivariate genomic datasets, and was a linchpin of the NIH
ENCODE Project analysis. He is a lead of the University Health Network (UHN) Indicators for Research Impact and Organizational Excellence Working Group and a consultant member of the UHN DORA Advisory Group.
Social Handles
https://hoffmanlab.org/
on Twitter
on LinkedIn
